Chinook Therapeutics, Inc. [ADRO]

Source: 

Company Overview

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Our pipeline is focused on rare, severe chronic kidney diseases with well-defined clinical pathways. Our lead clinical program is atrasentan, a potent and selective endothelin A receptor antagonist.